Altamira Therapeutics
CYTO
#10401
Rank
ยฃ0.88 M
Marketcap
๐Ÿ‡ง๐Ÿ‡ฒ
Country
ยฃ0.23
Share price
0.00%
Change (1 day)
-84.57%
Change (1 year)

EPS for Altamira Therapeutics (CYTO)

EPS in 2019 (TTM): -ยฃ235.16

According to Altamira Therapeutics's latest financial reports the company's current EPS (TTM) is -ยฃ240.83. In 2018 the company made an earnings per share (EPS) of -ยฃ339.16 an increase over its 2017 EPS that were of -ยฃ1,833.

EPS history for Altamira Therapeutics from 2013 to 2019

Annual EPS

Year EPS Change
2019 (TTM)-ยฃ235.16-30.67%
2018-ยฃ339.16-81.5%
2017-ยฃ1,833-36.52%
2016-ยฃ2,888-5.17%
2015-ยฃ3,0457.77%
2014-ยฃ2,8250.33%
2013-ยฃ2,816